MLchartDataset catalogue

carboxypeptidase-G2

Term · Oncology and biomedicine · MLC-T-ONC-001423

A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Carboxypeptidase-G2 is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Carboxypeptidase-G2 is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.

Table 1. Record
IdentifierMLC-T-ONC-001423
FieldOncology and biomedicine
Synonymsglucarpidase; Voraxaze
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001423",
  "term": "carboxypeptidase-G2",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Carboxypeptidase-G2 is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Carboxypeptidase-G2 is a type of chemoprotective agent and a type of prodrug activator. Also called glucarpidase and Voraxaze.",
  "synonyms": [
    "glucarpidase",
    "Voraxaze"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/carboxypeptidase-g2/"
}

Record 4,214 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.